Search bioRxiv⌕ Search

EXPLORE CONNECTIONS

Beyond the limitation of randomized controlled trials (RCTs)-current drug repositioning by using human induced pluripotent stem (iPS) cells technology-

Follow the relationships that help you find your next source.

Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.